Choose the Covid-19 Testing Service You Need:
RT-PCR Saliva Test
Safe, Accurate and Reliable
Results Within 48 Hours
an be used for travel in most circumstances. Includes expedited shipping to lab for processing.
The test is performed by Infinity BiologiX (a CLIA and CAP accredited laboratory) is a NAAT test (nucleic acid amplification test). This test is an RT PCR test and meets guidelines for most interstate and international travel, but please refer to the guidelines specified for entry to your destination.
The test is a qualitative test for the detection of nucleic acid from SARS-CoV-2 (RT-PCR). This kit will only test you for COVID-19 at the time that you give your sample. It is NOT an antigen test. It is NOT an antibody test. It does not determine whether you have had COVID-19 in the past or have developed antibodies for COVID-19.
For Return Flights Back to the U.S.
Results in 10 Minutes
Travelers originating in the U.S. and taking an international round-trip flight can order an at-home, virtually guided and medically supervised COVID-19 rapid antigen test to take with them for their return flight back to the U.S. Results in 10 minutes. No laboratory or equipment is required.
This is not a diagnostic test.
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Effective January 26, the Centers for Disease Control and Prevention (CDC) will require all air passengers entering the United States (including U.S. citizens and Legal Permanent Residents) to present a negative COVID-19 test, taken within three calendar days of departure, or proof of recovery from the virus within the last 90 days. Airlines must confirm the negative test result or proof of recent recovery for all passengers prior to boarding. Airlines must deny boarding of passengers who do not provide documentation of a negative test or recovery.
Shipping to U.S. addresses only.